Bio-Techne Wins Second Claim Of Reverse Engineering By Miltenyi Biotec
Bio-Techne Corp. (TECH), a life sciences company, announced Tuesday that it has won a second claim of reverse engineering by Miltenyi ...
Bio-Techne Corp. stock outperforms competitors on strong trading day
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
Can BAM Be a Trailblazer Again Through A.I.?
The Brooklyn organization, seeking new audiences and pushing boundaries, debuts Techne, four digital installations from the ...
Bio-Techne Corp. stock underperforms Thursday when compared to competitors
This was the stock's fourth consecutive day of losses.
Barchart on MSN15d
How Is Bio-Techne’s Stock Performance Compared to Other Biotechnology Stocks?
Bio-Techne Corporation (TECH), headquartered in Minneapolis, Minnesota, develops, manufactures, and sells life science ...
Bio-Techne在与Miltenyi Biotec的专利案中胜诉
明尼阿波利斯 - Bio-Techne Corporation (NASDAQ: TECH) 再次在与Miltenyi Biotec的法律纠纷中取得胜利，科隆地区法院裁定支持这家生命科学公司。法院认定Miltenyi Biotec非法销售从Bio-Techne专有的R&D Systems品牌NKG2C/CD159c抗体反向工程而来的抗体。
One in five voters who backed Tories in the election have switched to Nigel Farage’s Reform UK, new poll says
Techne UK’s final weekly tracker poll of the year gives Kemi Badenoch’s Tories a one point boost in the last seven days but ...
Yahoo Finance26d
Bio-Techne Launches ESR1 Mutation Monitoring Assay: Stock to Gain?
Bio-Techne Corp. TECH has launched a highly sensitive ESR1 mutation monitoring assay through its Asuragen brand. ESR1 gene mutations are known to be linked to hormone receptor-positive (HR+ ...
Bio-Techne Inks New Agreement With Waters Corporation: Stock to Gain?
TECH enters a co-marketing and co-promotion agreement with Waters Corporation to expand the reach of advanced biotherapeutic ...